SBIR-STTR Award

A Comprehensive 5K plus Glycan Microarray
Award last edited on: 2/19/2024

Sponsored Program
SBIR
Awarding Agency
NIH : NIGMS
Total Award Amount
$2,219,014
Award Phase
2
Solicitation Topic Code
859
Principal Investigator
Jian Zhang

Company Information

Z Biotech LLC

12635 East Montview Boulevard Suite 214
Aurora, CO 80045
   (720) 859-3551
   info@zbiotech.com
   www.zbiotech.com
Location: Single
Congr. District: 06
County: Adams

Phase I

Contract Number: 1R43GM123820-01A1
Start Date: 8/1/2017    Completed: 7/31/2019
Phase I year
2017
Phase I Amount
$154,935
There is growing need of high-throughput analytical platforms to study interactions of cell-surface glycans and glycan-binding proteins. We propose here to develop a 5K+ glycan array to facilitate functional glycomics research. Two hurdles for development of a comprehensive glycan array are (1) lack of a sensitive glycan array substrate enabling multivalent binding events, and (2) lack of a comprehensive glycan library of glycan structures representing the whole glycomes. To solve this challenge, Z Biotech will team with Chemily Glycoscience to deliver the most comprehensive glycan array and glycan sub-arrays to market. Z Biotech invented a robust microarray substrate having the advantage to display glycans on solid surface in multivalent form, and Chemily is a leading glycoscience company in production of complex glycans, sugar nucleotides and glycan-related enzymes. The proposed research strategy has been supported by a preliminary experimental investigation under collaboration between the two companies. In Phase I, our specific aims are (1) collection and synthesis of 1.2K+ glycans in 8 categories (sub-arrays), and (2) 1.2K+ glycan array manufacturing and QC/QA evaluation. Finally, the glycan arrays will be provided to large glycan array screening centers for further evaluation. These are realistic goals within a SBIR program frame and the resultant glycan array products will have a broad impact on glycobiology research, glycan-related biomarker characterization and new drug development.

Public Health Relevance Statement:
Project Narrative The multivalent glycan array substrates at Z Biotech LLC and glycan libraries at Chemily Glycoscience LLC have been defined as effective tools for glycomics research. At present there is no commercially available microarray representing the whole glycomes. This SBIR program seeks to leverage the resources and strength in the two companies and launch a sub-array formatted 5K+ glycan array onto market.

Project Terms:
Achievement Attainment; Achievement; aminoacid; Amino Acids; Animals; Antibodies; Bursa-Equivalent Lymphocyte; Bursa-Dependent Lymphocytes; B-cell; B-Cells; B cells; B cell; B blood cells; B-Lymphocytes; Biotech; Biotechnology; Carbohydrates; Cell-to-Cell Interaction; Cell Interaction; Cell Communication; plasmalemma; Plasma Membrane; Cytoplasmic Membrane; Cell membrane; Chemistry; Engineering; Enzyme Gene; Enzymes; Family; Sialoglycosphingolipids; Gangliosides; GAG; GAG Gene; Goals; Modern Man; Human; Immobilization; orthopedic freezing; Industrialization; Lectin; Libraries; Lipids; Mission; Noise; Oligosaccharides; Plants; Polysaccharides; Glycans; Production; Proteins; Research; Research Personnel; Researchers; Investigators; Resources; Research Resources; Signal Transduction; biological signal transduction; Signaling; Signal Transduction Systems; Intracellular Communication and Signaling; Cell Signaling; Cell Communication and Signaling; Specificity; Technology; Vaccines; Work; Generations; Mediating; S-7; base; macromolecule; Surface; Solid; Phase; Variation; Variant; Biological; Evaluation; bound protein; Protein Binding; Ligand Binding Protein Gene; Ligand Binding Protein; Binding Proteins; Collaborations; Therapeutic; Liquid substance; liquid; fluid; tool; programs; Investigation; Complex; Event; System; carbohydrate receptor; protein bound carbohydrate; Performance; receptor; Receptor Protein; success; sugar nucleotide; molecular recognition; Structure; Categories; new technology; novel technologies; Cell surface; drug development; S-1 Antimetabolite agent; S-1; Binding; Molecular Interaction; Data; Glycobiology; Collection; Small Business Innovation Research; SBIR; Small Business Innovation Research Grant; Validation; Characteristics; developmental; Development; innovation; innovative; innovate; novel therapeutics; novel therapy; novel drugs; novel drug treatments; next generation therapeutics; new therapy; new therapeutics; new drugs; new drug treatments; comparative; commercial application; Biological Markers; biomarker; biologic marker; bio-markers; screening; Natural Products

Phase II

Contract Number: 5R43GM123820-02
Start Date: 8/1/2017    Completed: 7/31/2020
Phase II year
2018
(last award dollars: 2023)
Phase II Amount
$2,064,079

There is growing need of high-throughput analytical platforms to study interactions of cell-surface glycans and glycan-binding proteins. We propose here to develop a 5K+ glycan array to facilitate functional glycomics research. Two hurdles for development of a comprehensive glycan array are (1) lack of a sensitive glycan array substrate enabling multivalent binding events, and (2) lack of a comprehensive glycan library of glycan structures representing the whole glycomes. To solve this challenge, Z Biotech will team with Chemily Glycoscience to deliver the most comprehensive glycan array and glycan sub-arrays to market. Z Biotech invented a robust microarray substrate having the advantage to display glycans on solid surface in multivalent form, and Chemily is a leading glycoscience company in production of complex glycans, sugar nucleotides and glycan-related enzymes. The proposed research strategy has been supported by a preliminary experimental investigation under collaboration between the two companies. In Phase I, our specific aims are (1) collection and synthesis of 1.2K+ glycans in 8 categories (sub-arrays), and (2) 1.2K+ glycan array manufacturing and QC/QA evaluation. Finally, the glycan arrays will be provided to large glycan array screening centers for further evaluation. These are realistic goals within a SBIR program frame and the resultant glycan array products will have a broad impact on glycobiology research, glycan-related biomarker characterization and new drug development.

Public Health Relevance Statement:
Project Narrative The multivalent glycan array substrates at Z Biotech LLC and glycan libraries at Chemily Glycoscience LLC have been defined as effective tools for glycomics research. At present there is no commercially available microarray representing the whole glycomes. This SBIR program seeks to leverage the resources and strength in the two companies and launch a sub-array formatted 5K+ glycan array onto market.

Project Terms:
Achievement; Achievement Attainment; Amino Acids; aminoacid; Animals; Antibodies; B-Lymphocytes; Bursa-Equivalent Lymphocyte; Bursa-Dependent Lymphocytes; B-cell; B-Cells; B cells; B cell; B blood cells; Biotechnology; Biotech; Carbohydrates; Cell Communication; Cell-to-Cell Interaction; Cell Interaction; Cell membrane; plasmalemma; Plasma Membrane; Cytoplasmic Membrane; Chemistry; Engineering; Enzymes; Enzyme Gene; Family; Gangliosides; Sialoglycosphingolipids; GAG Gene; GAG; Goals; Human; Modern Man; Immobilization; orthopedic freezing; Industrialization; Lectin; Libraries; Lipids; Mission; Noise; Oligosaccharides; Plants; Polysaccharides; Glycans; Production; Proteins; Research; Research Personnel; Researchers; Investigators; Resources; Research Resources; Signal Transduction; biological signal transduction; Signaling; Signal Transduction Systems; Intracellular Communication and Signaling; Cell Signaling; Cell Communication and Signaling; Specificity; Technology; Vaccines; Work; Generations; Mediating; S-7; base; macromolecule; Surface; Solid; Phase; Variation; Variant; Biological; Evaluation; bound protein; Protein Binding; Ligand Binding Protein Gene; Ligand Binding Protein; Binding Proteins; Collaborations; Therapeutic; Liquid substance; liquid; fluid; tool; programs; Investigation; Complex; Event; System; carbohydrate receptor; protein bound carbohydrate; Performance; receptor; Receptor Protein; success; sugar nucleotide; molecular recognition; Structure; Categories; new technology; novel technologies; Cell surface; drug development; S-1 Antimetabolite agent; S-1; Binding; Molecular Interaction; Data; Glycobiology; Collection; Small Business Innovation Research; SBIR; Small Business Innovation Research Grant; Validation; Characteristics; developmental; Development; innovative; innovate; innovation; novel therapy; novel drugs; novel drug treatments; next generation therapeutics; new therapy; new therapeutics; new drugs; new drug treatments; novel therapeutics; comparative; commercial application; biomarker; biologic marker; bio-markers; Biological Markers; screening; Natural Products